Snhg8-flox Mouse
Common Name
Snhg8-flox
제품 ID
S-CKO-14682
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-69895-Snhg8-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Snhg8-flox Mouse (카탈로그 번호 S-CKO-14682)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Snhg8-flox
품종 계통계통 ID
CKOCMP-69895-Snhg8-B6J-VA
유전자명
제품 ID
S-CKO-14682
유전자 별칭
1110065M07Rik, 2010109N14Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 3
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000196466
NCBI 전사체 ID
--
타겟 영역
Exon 1~3
유효 영역 크기
~1.9 kb
유전자 연구 개요
Snhg8, short for Small nucleolar RNA host gene 8, is a long non-coding RNA. It has physiological roles in epithelial and muscle satellite cells. Snhg8 can act as a molecular sponge for multiple miRNAs, regulating various target genes, and is involved in diverse biological processes and signaling pathways. Its dysregulation is associated with many human disorders, making it an important gene for understanding disease mechanisms [1].
In tauopathies, Snhg8 was significantly reduced in a mouse model and in affected human brains. Overexpression of mutant tau reduced Snhg8 expression and induced stress granule formation, while rescuing Snhg8 expression decreased stress granule formation, suggesting Snhg8 dysregulation drives stress granule formation via TIA1 in tauopathies [2].
In multiple cancer types like gastric, breast, and nasopharyngeal carcinomas, Snhg8 knockdown inhibited tumor cell proliferation, migration, and invasion. For example, in EBV-associated gastric cancer, Snhg8 promoted tumorigenesis and invasion by sponging miR-512-5p and upregulating TRIM28 [3]. In breast cancer, it functioned through the miR-634/ZBTB20 axis [4], and in nasopharyngeal carcinoma, via the miR-588/HMGA2 axis [5].
In osteogenic differentiation of periodontal ligament stem cells (PDLSCs), mechanical force decreased Snhg8 expression, which promoted osteogenic differentiation. Knockdown of Snhg8 in PDLSCs increased osteogenic-related gene expression [6].
In cerebral ischemia-reperfusion injury in mice, LncRNA Snhg8 improved the injury by inhibiting miR-494-3p expression, suppressing microglia inflammatory reactions and apoptosis [7].
In high-glucose-induced endothelial cell injury, silencing lncRNA Snhg8 reversed the decrease in eNOS activation, NO production, migration, and angiogenesis of primary human umbilical vein endothelial cells (pHUVECs) [8].
In diffuse large B-cell lymphoma, knockdown of Snhg8 inhibited cell proliferation and colony formation while promoting apoptosis by targeting miR-335-5p [9].
In nasopharyngeal carcinoma, Snhg8 promoted aggressive behaviors via regulating the miR-656-3p/SATB1 axis [10].
In conclusion, Snhg8 is a crucial long non-coding RNA involved in various biological processes and disease conditions. Studies using gene-knockout or knockdown models in different tissues and disease models have revealed its role in cancer progression, neurodegenerative diseases, osteogenic differentiation, and ischemia-reperfusion injury. These findings contribute to a better understanding of the molecular mechanisms underlying these diseases and may provide potential therapeutic targets.
References:
1. Ghafouri-Fard, Soudeh, Harsij, Atefeh, Hussen, Bashdar Mahmud, Taheri, Mohammad, Ayatollahi, Seyed Abdulmajid. 2023. A review on the role of SNHG8 in human disorders. In Pathology, research and practice, 245, 154458. doi:10.1016/j.prp.2023.154458. https://pubmed.ncbi.nlm.nih.gov/37043963/
2. Bhagat, Reshma, Minaya, Miguel A, Renganathan, Arun, Grinberg, Lea T, Karch, Celeste M. 2023. Long non-coding RNA SNHG8 drives stress granule formation in tauopathies. In Molecular psychiatry, 28, 4889-4901. doi:10.1038/s41380-023-02237-2. https://pubmed.ncbi.nlm.nih.gov/37730840/
3. Zou, Changyan, Liao, Jinrong, Hu, Dan, Huang, Tao, Lin, Xiandong. 2021. SNHG8 Promotes the Progression of Epstein-Barr Virus-Associated Gastric Cancer via Sponging miR-512-5p and Targeting TRIM28. In Frontiers in oncology, 11, 734694. doi:10.3389/fonc.2021.734694. https://pubmed.ncbi.nlm.nih.gov/34722282/
4. Xu, Xianyun, Xie, Qiongjun, Xie, Mingfeng, Zeng, Yong, Liu, Qian. 2021. LncRNA SNHG8 Serves as an Oncogene in Breast Cancer Through miR-634/ZBTB20 Axis. In Cancer management and research, 13, 3017-3028. doi:10.2147/CMAR.S270128. https://pubmed.ncbi.nlm.nih.gov/33854372/
5. Luan, Qiang, Yang, Ruifang, Lin, Lejun, Li, Xuecheng. 2022. SNHG8 promotes cell proliferation, migration, and invasion of nasopharyngeal carcinoma cells as an oncogene through miR-588/HMGA2 axis. In Canadian journal of physiology and pharmacology, 100, 158-166. doi:10.1139/cjpp-2021-0149. https://pubmed.ncbi.nlm.nih.gov/35080988/
6. Zhang, Zijie, He, Qin, Yang, Shuangyan, Li, Xiaoyu, Wei, Fulan. 2022. Mechanical force-sensitive lncRNA SNHG8 inhibits osteogenic differentiation by regulating EZH2 in hPDLSCs. In Cellular signalling, 93, 110285. doi:10.1016/j.cellsig.2022.110285. https://pubmed.ncbi.nlm.nih.gov/35192931/
7. Cao, T, Liu, Q, Pan, M, Zhang, X. . [LncRNA SNHG8 inhibits miR-494-3p expression to alleviate cerebral ischemia-reperfusion injury in mice]. In Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 43, 2015-2022. doi:10.12122/j.issn.1673-4254.2023.12.04. https://pubmed.ncbi.nlm.nih.gov/38189386/
8. Fan, Zongcheng, Chen, Xin, Wang, Laicheng, Lin, Yunchai, Peng, Feng. 2023. LncRNA SNHG8 regulates the migration and angiogenesis of pHUVECs induced by high glucose via the TRPM7/ERK1/2 signaling axis. In Scientific reports, 13, 22485. doi:10.1038/s41598-023-49779-7. https://pubmed.ncbi.nlm.nih.gov/38110485/
9. Yu, Bing, Wang, Bo, Wu, Zhuman, Gao, Xiaoyan, Zeng, Huilan. 2021. LncRNA SNHG8 Promotes Proliferation and Inhibits Apoptosis of Diffuse Large B-Cell Lymphoma via Sponging miR-335-5p. In Frontiers in oncology, 11, 650287. doi:10.3389/fonc.2021.650287. https://pubmed.ncbi.nlm.nih.gov/33816305/
10. Tian, Xiaoyan, Liu, Yuehui, Wang, Zhi, Wu, Shuhong. 2020. lncRNA SNHG8 promotes aggressive behaviors of nasopharyngeal carcinoma via regulating miR-656-3p/SATB1 axis. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 131, 110564. doi:10.1016/j.biopha.2020.110564. https://pubmed.ncbi.nlm.nih.gov/32920509/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
